| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/16/2011 | US20110144199 Methods for treating atrial fibrillation |
| 06/16/2011 | US20110144197 Alcanoic acid amides substituted by saturated o-heterocycles |
| 06/16/2011 | US20110144193 Pharmaceutical Composition Comprising Cinchonains Ia And Ib, Process For Preparing An Epimeric Mixture Of Cinchonains Ia And Ib, Use And Method For Reverting/Combating Ventricular Fibrillation |
| 06/16/2011 | US20110144192 Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144150 Bridged bicyclic rho kinase inhibitor compounds, composition and use |
| 06/16/2011 | US20110144148 Acetylcholinesterase dual inhibitors |
| 06/16/2011 | US20110144145 Methods for treating visceral fat conditions |
| 06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144133 Substituted pyrimidone derivatives |
| 06/16/2011 | US20110144125 Anti-Arrhythmia Agents, Methods of Their Use, Methods of Their Identification and Kits Therefore |
| 06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 06/16/2011 | US20110144116 DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS |
| 06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/16/2011 | US20110144114 Substituted triazinone derivatives |
| 06/16/2011 | US20110144113 Triazolotriazines as kinase inhibitors |
| 06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144087 Short acting benzothiazepine calcium channel blockers and uses thereof |
| 06/16/2011 | US20110144078 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144067 N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110144055 Health Care |
| 06/16/2011 | US20110144052 Niacin prodrugs and deuterated versions thereof |
| 06/16/2011 | US20110144051 Compositions and methods for treatment of mitochondrial diseases |
| 06/16/2011 | US20110144049 Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
| 06/16/2011 | US20110144038 Human cd154-binding synthetic peptide and uses thereof |
| 06/16/2011 | US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use |
| 06/16/2011 | US20110144028 Modulating cellular electrophysiology |
| 06/16/2011 | US20110144026 Method of Treating Low Blood Pressure |
| 06/16/2011 | US20110144019 Method of treating chronic heart failure |
| 06/16/2011 | US20110144018 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110144013 VEGF-D Mutants and Their Use |
| 06/16/2011 | US20110144009 Brown Adipocyte Progenitors in Human Skeletal Muscle |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110143993 Endothelial basement membrane targeting peptide ligands |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142967 Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent |
| 06/16/2011 | US20110142947 Novel formulations |
| 06/16/2011 | US20110142935 Cardiac differentiation of human pluripotent stem cells under defined conditions using matrix overlay methods |
| 06/16/2011 | US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142913 Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug |
| 06/16/2011 | US20110142904 Methods for the In Situ Treatment of Bone Cancer |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142883 Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts |
| 06/16/2011 | US20110142880 Lentivirus-based immunogenic vectors |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142850 Method of treating cd40-mediated diseases |
| 06/16/2011 | US20110142849 Pcsk9 antagonists |
| 06/16/2011 | US20110142818 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 06/16/2011 | US20110142804 Nanofiber scaffold |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142787 Polymerized cyclic nitroxide radical compound and use thereof |
| 06/16/2011 | US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
| 06/16/2011 | US20110139654 Oxadiazole derivatives for the treatment of diabetes |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2782294A1 Cysteine protease inhibitors |
| 06/16/2011 | CA2782292A1 Cysteine protease inhibitors |
| 06/16/2011 | CA2782248A1 Bis-acylated hydroxylamine derivatives |
| 06/16/2011 | CA2782110A1 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives |
| 06/16/2011 | CA2781888A1 Agents and methods for treating ischemic and other diseases |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332953A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332580A1 A composition for the treatment of the central nervous system |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332578A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/15/2011 | EP2332568A1 Collagenase for opening obstructed biological conduits |
| 06/15/2011 | EP2332553A1 Methods and compositions to treat myocardial conditions |
| 06/15/2011 | EP2332552A2 Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity |
| 06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
| 06/15/2011 | EP2332549A1 Novel tetracyclines and their use in medicine |
| 06/15/2011 | EP2332548A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
| 06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332535A1 Solid pharmaceutical composition |
| 06/15/2011 | EP2332533A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 06/15/2011 | EP2332527A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 06/15/2011 | EP2332526A2 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 06/15/2011 | EP2332424A1 Method for producing lipid |
| 06/15/2011 | EP2331551A1 Thienopyrimidines for pharmaceutical compositions |
| 06/15/2011 | EP2331541A1 Indolizine inhibitors of leukotriene production |
| 06/15/2011 | EP2331135A1 Methods of treating and preventing glucose toxicity |